Motivators and barriers of tamoxifen use as risk-reducing medication amongst women at increased breast cancer risk: a systematic literature review.
- DOI
- 10.1186/s13053-017-0075-8
- Published
- 2017
- Container
- Hereditary cancer in clinical practice
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s13053-017-0075-8,
title = {Motivators and barriers of tamoxifen use as risk-reducing medication amongst women at increased breast cancer risk: a systematic literature review.},
author = {Meiser B and Wong WKT and Peate M and Julian-Reynier C and Kirk J and Mitchell G},
year = {2017},
journal = {Hereditary cancer in clinical practice},
doi = {10.1186/s13053-017-0075-8},
url = {https://doi.org/10.1186/s13053-017-0075-8}
}RIS
TY - JOUR TI - Motivators and barriers of tamoxifen use as risk-reducing medication amongst women at increased breast cancer risk: a systematic literature review. AU - Meiser B AU - Wong WKT AU - Peate M AU - Julian-Reynier C AU - Kirk J AU - Mitchell G PY - 2017 JO - Hereditary cancer in clinical practice DO - 10.1186/s13053-017-0075-8 UR - https://doi.org/10.1186/s13053-017-0075-8 ER -
APA
B, M., WKT, W., M, P., C, J., J, K., & G, M. (2017). Motivators and barriers of tamoxifen use as risk-reducing medication amongst women at increased breast cancer risk: a systematic literature review.. Hereditary cancer in clinical practice. https://doi.org/10.1186/s13053-017-0075-8
Source records
- pubmed · retrieved 2026-09-25T12:52:25.808Z